A Phase 1 Study to Evaluate the Pharmacokinetics and Tolerability of Tralokinumab When Delivered at Different Flow Rates to Healthy Volunteers

Trial Profile

A Phase 1 Study to Evaluate the Pharmacokinetics and Tolerability of Tralokinumab When Delivered at Different Flow Rates to Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jul 2017

At a glance

  • Drugs Tralokinumab (Primary)
  • Indications Asthma
  • Focus Pharmacokinetics
  • Sponsors MedImmune
  • Most Recent Events

    • 30 Jun 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Jun 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 23 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top